Identification	B:C0020792
and	O
SAR	O
Evaluation	O
of	O
Hemozoin	O
-	O
Inhibiting	O
Benzamides	O
Active	O
against	O
Plasmodium	O
falciparum	I:C0032150
.	O

Identification	O
and	O
SAR	O
Evaluation	B:C0220825
of	O
Hemozoin	O
-	O
Inhibiting	O
Benzamides	O
Active	O
against	O
Plasmodium	O
falciparum	I:C0032150
.	O

Identification	O
and	O
SAR	O
Evaluation	O
of	O
Hemozoin	B:C0062496
-	O
Inhibiting	O
Benzamides	O
Active	O
against	O
Plasmodium	O
falciparum	I:C0032150
.	O

Identification	O
and	O
SAR	O
Evaluation	O
of	O
Hemozoin	O
-	O
Inhibiting	O
Benzamides	B:C0005029
Active	O
against	O
Plasmodium	O
falciparum	I:C0032150
.	O

Identification	O
and	O
SAR	O
Evaluation	O
of	O
Hemozoin	O
-	O
Inhibiting	O
Benzamides	O
Active	O
against	O
Plasmodium	B:C0032150
falciparum	I:C0032150
.	O

Quinoline	B:C0034423
antimalarials	O
target	O
hemozoin	O
formation	O
causing	O
a	O
cytotoxic	O
accumulation	O
of	O
ferriprotoporphyrin	O
IX	I:C0015877
(	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
)	O
.	O

Quinoline	O
antimalarials	B:C0003374
target	O
hemozoin	O
formation	O
causing	O
a	O
cytotoxic	O
accumulation	O
of	O
ferriprotoporphyrin	O
IX	I:C0015877
(	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
)	O
.	O

Quinoline	O
antimalarials	O
target	O
hemozoin	B:C0062496
formation	O
causing	O
a	O
cytotoxic	O
accumulation	O
of	O
ferriprotoporphyrin	O
IX	I:C0015877
(	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
)	O
.	O

Quinoline	O
antimalarials	O
target	O
hemozoin	O
formation	O
causing	O
a	O
cytotoxic	O
accumulation	B:C4055506
of	O
ferriprotoporphyrin	O
IX	I:C0015877
(	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
)	O
.	O

Quinoline	O
antimalarials	O
target	O
hemozoin	O
formation	O
causing	O
a	O
cytotoxic	O
accumulation	O
of	O
ferriprotoporphyrin	B:C0015877
IX	I:C0015877
(	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
)	O
.	O

Quinoline	O
antimalarials	O
target	O
hemozoin	O
formation	O
causing	O
a	O
cytotoxic	O
accumulation	O
of	O
ferriprotoporphyrin	O
IX	I:C0015877
(	O
Fe(	B:C0015877
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
)	O
.	O

Well	O
-	O
developed	O
SAR	O
models	B:C3161035
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	B:C0062496
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	B:C0030498
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	B:C1148560
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	B:C0456387
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	B:C0243095
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	B:C0062496
inhibiting	O
chemotypes	O
.	O

Well	O
-	O
developed	O
SAR	O
models	O
exist	O
for	O
β-	O
hematin	I:C0062496
inhibition	O
,	O
parasite	O
activity	O
,	O
and	O
cellular	O
mechanisms	I:C1148560
for	O
this	O
compound	O
class	I:C0456387
,	O
but	O
no	O
comparably	O
detailed	O
investigations	O
exist	O
for	O
other	O
hemozoin	O
inhibiting	O
chemotypes	B:C1254351
.	O

Here	O
,	O
benzamide	B:C0053139
analogues	O
based	O
on	O
previous	O
HTS	O
hits	O
have	O
been	O
purchased	O
or	O
synthesized	O
.	O

Here	O
,	O
benzamide	O
analogues	B:C0002776
based	O
on	O
previous	O
HTS	O
hits	O
have	O
been	O
purchased	O
or	O
synthesized	O
.	O

Here	O
,	O
benzamide	O
analogues	O
based	O
on	O
previous	O
HTS	B:C2718003
hits	O
have	O
been	O
purchased	O
or	O
synthesized	O
.	O

Only	O
derivatives	B:C0243072
containing	I:C0243072
an	I:C0243072
electron	I:C0243072
deficient	I:C0243072
aromatic	I:C0243072
ring	I:C0243072
and	O
capable	O
of	O
adopting	O
flat	O
conformations	I:C0026377
,	O
optimal	O
for	O
π-π	O
interactions	O
with	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
,	O
inhibited	O
β-	O
hematin	I:C0062496
formation	O
.	O

Only	O
derivatives	O
containing	I:C0243072
an	I:C0243072
electron	I:C0243072
deficient	I:C0243072
aromatic	I:C0243072
ring	I:C0243072
and	O
capable	O
of	O
adopting	O
flat	B:C0026377
conformations	I:C0026377
,	O
optimal	O
for	O
π-π	O
interactions	O
with	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
,	O
inhibited	O
β-	O
hematin	I:C0062496
formation	O
.	O

Only	O
derivatives	O
containing	I:C0243072
an	I:C0243072
electron	I:C0243072
deficient	I:C0243072
aromatic	I:C0243072
ring	I:C0243072
and	O
capable	O
of	O
adopting	O
flat	O
conformations	I:C0026377
,	O
optimal	O
for	O
π-π	O
interactions	O
with	O
Fe(	B:C0015877
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
,	O
inhibited	O
β-	O
hematin	I:C0062496
formation	O
.	O

Only	O
derivatives	O
containing	I:C0243072
an	I:C0243072
electron	I:C0243072
deficient	I:C0243072
aromatic	I:C0243072
ring	I:C0243072
and	O
capable	O
of	O
adopting	O
flat	O
conformations	I:C0026377
,	O
optimal	O
for	O
π-π	O
interactions	O
with	O
Fe(	O
III	I:C0015877
)	I:C0015877
PPIX	I:C0015877
,	O
inhibited	O
β-	B:C0062496
hematin	I:C0062496
formation	O
.	O

The	O
two	O
most	O
potent	O
analogues	B:C0002776
showed	O
nanomolar	O
parasite	O
activity	O
,	O
with	O
little	O
CQ	O
cross-resistance	O
,	O
low	O
cytotoxicity	O
,	O
and	O
high	O
in	O
vitro	O
microsomal	O
stability	O
.	O

The	O
two	O
most	O
potent	O
analogues	O
showed	O
nanomolar	O
parasite	B:C0030498
activity	O
,	O
with	O
little	O
CQ	O
cross-resistance	O
,	O
low	O
cytotoxicity	O
,	O
and	O
high	O
in	O
vitro	O
microsomal	O
stability	O
.	O

The	O
two	O
most	O
potent	O
analogues	O
showed	O
nanomolar	O
parasite	O
activity	O
,	O
with	O
little	O
CQ	B:C0008269
cross-resistance	O
,	O
low	O
cytotoxicity	O
,	O
and	O
high	O
in	O
vitro	O
microsomal	O
stability	O
.	O

The	O
two	O
most	O
potent	O
analogues	O
showed	O
nanomolar	O
parasite	O
activity	O
,	O
with	O
little	O
CQ	O
cross-resistance	B:C2363980
,	O
low	O
cytotoxicity	O
,	O
and	O
high	O
in	O
vitro	O
microsomal	O
stability	O
.	O

The	O
two	O
most	O
potent	O
analogues	O
showed	O
nanomolar	O
parasite	O
activity	O
,	O
with	O
little	O
CQ	O
cross-resistance	O
,	O
low	O
cytotoxicity	B:C0596402
,	O
and	O
high	O
in	O
vitro	O
microsomal	O
stability	O
.	O

Selected	O
analogues	B:C0002776
inhibited	O
hemozoin	O
formation	O
in	O
Plasmodium	O
falciparum	I:C0032150
causing	O
high	O
levels	O
of	O
free	O
heme	O
.	O

Selected	O
analogues	O
inhibited	O
hemozoin	B:C0062496
formation	O
in	O
Plasmodium	O
falciparum	I:C0032150
causing	O
high	O
levels	O
of	O
free	O
heme	O
.	O

Selected	O
analogues	O
inhibited	O
hemozoin	O
formation	O
in	O
Plasmodium	B:C0032150
falciparum	I:C0032150
causing	O
high	O
levels	O
of	O
free	O
heme	O
.	O

Selected	O
analogues	O
inhibited	O
hemozoin	O
formation	O
in	O
Plasmodium	O
falciparum	I:C0032150
causing	O
high	O
levels	O
of	O
free	O
heme	B:C0018966
.	O

In	O
contrast	O
to	O
quinolines	B:C0034424
,	O
introduction	O
of	O
amine	O
side	O
chains	O
did	O
not	O
lead	O
to	O
benzamide	O
accumulation	O
in	O
the	O
parasite	O
.	O

In	O
contrast	O
to	O
quinolines	O
,	O
introduction	O
of	O
amine	O
side	O
chains	O
did	O
not	O
lead	O
to	O
benzamide	B:C0053139
accumulation	O
in	O
the	O
parasite	O
.	O

In	O
contrast	O
to	O
quinolines	O
,	O
introduction	O
of	O
amine	O
side	O
chains	O
did	O
not	O
lead	O
to	O
benzamide	O
accumulation	B:C4055506
in	O
the	O
parasite	O
.	O

In	O
contrast	O
to	O
quinolines	O
,	O
introduction	O
of	O
amine	O
side	O
chains	O
did	O
not	O
lead	O
to	O
benzamide	O
accumulation	O
in	O
the	O
parasite	B:C0030498
.	O

These	O
data	O
reveal	O
complex	O
relationships	O
between	O
heme	B:C1148616
binding	I:C1148616
,	O
free	O
heme	O
levels	O
,	O
cellular	O
accumulation	I:C0007613
,	O
and	O
in	O
vitro	O
activity	O
of	O
potential	O
novel	O
antimalarials	O
.	O

These	O
data	O
reveal	O
complex	O
relationships	O
between	O
heme	O
binding	I:C1148616
,	O
free	O
heme	B:C0018966
levels	O
,	O
cellular	O
accumulation	I:C0007613
,	O
and	O
in	O
vitro	O
activity	O
of	O
potential	O
novel	O
antimalarials	O
.	O

These	O
data	O
reveal	O
complex	O
relationships	O
between	O
heme	O
binding	I:C1148616
,	O
free	O
heme	O
levels	O
,	O
cellular	B:C0007613
accumulation	I:C0007613
,	O
and	O
in	O
vitro	O
activity	O
of	O
potential	O
novel	O
antimalarials	O
.	O

These	O
data	O
reveal	O
complex	O
relationships	O
between	O
heme	O
binding	I:C1148616
,	O
free	O
heme	O
levels	O
,	O
cellular	O
accumulation	I:C0007613
,	O
and	O
in	O
vitro	O
activity	O
of	O
potential	O
novel	O
antimalarials	B:C0003374
.	O

